The cost of cancer care is not related to its outcomes

Solid tumours make up 90% of all proliferative diseases and the main action for cure remains surgery, removing the visible tumour as well as the surrounding tissue. Radiotherapy is an added value for eliminating local microscopic as well as regional disease. Systemic treatment has a small impact on...

Descripción completa

Detalles Bibliográficos
Autores principales: Storme, Guy, Dhaese, S, Corens, D, De Ridder, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2016
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130330/
https://www.ncbi.nlm.nih.gov/pubmed/27994643
http://dx.doi.org/10.3332/ecancer.2016.687
Descripción
Sumario:Solid tumours make up 90% of all proliferative diseases and the main action for cure remains surgery, removing the visible tumour as well as the surrounding tissue. Radiotherapy is an added value for eliminating local microscopic as well as regional disease. Systemic treatment has a small impact on the outcome but has a cost, which is as much as all the other actions such as diagnostic tools and treatments.

Ejemplares similares